Welcome to DiagnosticON
Welcome to DiagnosticON
DiagnosticON, an AI-based health-tech company specializing in predicting rehospitalization risks for patients suffering from Acute Myocardial Infarction (AMI) and Heart Failure (HF), is eager to explore opportunities for collaboration with the MedTech and Pharma industries. We firmly believe in the power of collaboration to drive innovation and improve patient care.
Our sophisticated AI models, developed through rigorous research and testing, have proven their ability to deliver accurate risk assessments and effectively predict patient readmission rates. However, we recognize that to fully leverage the potential of our AI solutions, strategic partnerships with MedTech and Pharma companies are essential.
By partnering with MedTech and Pharma companies that offer complementary products and services, we hope to integrate our AI technology in new and innovative ways.
We are particularly interested in partnering with organizations that share our vision for the future of healthcare: a future driven by AI and predictive medicine. We envision our AI models working in concert with other technologies and pharmaceuticals, providing healthcare professionals with the most accurate, comprehensive information possible, thus enabling them to make the best decisions for their patients.
If your organization is pioneering innovative products or services in the MedTech or Pharma industries and you see potential for our AI solutions to enhance your offerings, we would love to hear from you. Please contact us at [email contact] or use our online contact form on the website. Together, we can revolutionize healthcare delivery and improve the lives of patients globally.
We are open to both global and local partnerships. We believe that collaboration at all levels can lead to significant innovations and advancements in healthcare.
Yes, our collaboration scope includes partnerships with distributors. We believe in partnering with organizations that can help us broaden the reach of our AI solutions, and distributors play a key role in this.
DiagnosticON is currently active in several markets including the United States, European Union, Australia, and the United Arab Emirates. We continue to explore opportunities to expand our presence in other regions.